Karen Akinsanya - Mar 30, 2022 Form 3 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Director
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Stock symbol
NAUT
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
3
Date filed
3/31/2022, 06:13 PM
Previous filing
Feb 9, 2022
Next filing
Jun 16, 2022

No securities are beneficially owned.

Remarks:

No Securities beneficially held